Clinical Trial Update: Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data

View source ↗

Summary

A completed non-interventional observational study evaluated gender-specific data for nevirapine (Viramune) in HIV treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viramune (Nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Status: COMPLETED | Results posted: 2015-01-21